HEIDI NIXON: Open Payments
NPI 1568885135 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 34 payments from 5 companies in 2025. Trend: 2023 $424 · 2024 $640 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $155 |
| Lilly USA, LLC | 9 | $144 |
| Novo Nordisk Inc | 14 | $139 |
| ABBVIE INC. | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
Products named: Korlym, Wegovy, MOUNJARO, RECORLEV, UBRELVY, QULIPTA, ZEPBOUND, Ozempic.
Industry payments across WA — which companies pay providers there.
